Drug Repositioning Applied to Cardiovascular Disease in Mucopolysaccharidosis

Mucopolysaccharidoses (MPS) are genetic metabolic diseases characterized by defects in the activity of lysosomal hydrolases. In MPS, secondary cell disturbance affects pathways related to cardiovascular disorders. Hence, the study aimed to identify MPS-related drugs targeting cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Villalba Silva, Gerda Cristal, Steindorff, Thiago, Silvestri Schuh, Roselena, Cardoso Flores, Natalia, Matte, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784427/
https://www.ncbi.nlm.nih.gov/pubmed/36556450
http://dx.doi.org/10.3390/life12122085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784427/
https://www.ncbi.nlm.nih.gov/pubmed/36556450
http://dx.doi.org/10.3390/life12122085

Ejemplares similares